Diabetes News

Endocrinology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Timmers HJLM et al. - For tumour localization, 18F-FDA PET and 123/131I-MIBG scintigraphy perform equally well in patients with non-metastatic PHEO, but metastases are better detected by 18F-FDA PET than by 123/131I-MIBG.

Related Articles

Magnesium Sulphate as Rescue Haemodynamic Stabilizer During Phaeochromocytoma Excision
Journal of Anaesthesiology Clinical Pharmacology, 10/20/09    Relevance Score: 88%

Today in Adrenal Glands...keeping you current

Evaluation of antioxidant systems in pituitary-adrenal axis diseases
Pituitary, 12/18/09

Psychosomatic aspects of Cushings syndrome
Reviews in Endocrine and Metabolic Disease, 12/18/09

Adrenal incidentalomas in the laparoscopic era and the role of correct surgical indications: observations from 255 consecutive adrenalectomies in an Italian series
Canadian Journal of Surgery, 12/18/09